Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain

Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain

Interferons (IFNs) are cytokines with diverse functions, possessing antiviral, antiproliferative, and immunomodulatory effects. IFN-α and IFN-β, key members of the type I interferon (IFN-I) family, are widely used in the treatment of diseases such as hepatitis and multiple sclerosis. In the nervous...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ti-Chuan Chiu, Yu-Yu Li, Chia-Hung Yu, Kuo-Chuan Hung, Chin-Chen Chu, Ping-Hsun Feng, Ping-Heng Tan
Format:	Article
Language:	English
Published:	IMR Press 2025-06-01
Series:	Journal of Integrative Neuroscience
Subjects:	nociceptive response type i interferon sting ifn-α ifn-β type i interferon receptor
Online Access:	https://www.imrpress.com/journal/JIN/24/6/10.31083/JIN33414
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interferon Status and Choice of Interferons Inducers in Frequently Ill Children
by: M. S. Savenkovа, et al.
Published: (2016-06-01)

The concerted actions of microRNA-29a and interferon-β modulate complete Freund's adjuvant-induced inflammatory pain by regulating the expression of type 1 interferon receptor, interferon-stimulated gene 15, and p-extracellular signal-regulated kinase
by: Chien-Cheng Liu, et al.
Published: (2025-03-01)

CONGENITAL AND ACQUIRED INTERFERONOPATHIES: DIFFERENTIATED APPROACHES TO THE INTERFERON-CORRECTIVE THERAPY
by: I. V. Nesterova
Published: (2017-07-01)

Profiling type I and II interferon responses reveals distinct subgroups of pediatric patients with autoinflammatory disorders
by: Anaïs Nombel, PharmD, et al.
Published: (2025-05-01)

Clinical significance of interferon status in patients with systemic lupus erythematosus. Preliminary data
by: T. A. Panafidina, et al.
Published: (2025-03-01)

The Role of Anti-Interferon-α Autoantibodies in Severe COVID-19: Implications for Vaccination Prioritization
by: Xin Rong Lim, et al.
Published: (2025-07-01)

Therapeutically targeting proinflammatory type I interferons in systemic lupus erythematosus: efficacy and insufficiency with a specific focus on lupus nephritis
by: Benjamin Lai, et al.
Published: (2024-10-01)

The Role of Sustained Type I Interferon Secretion in Chronic HIV Pathogenicity: Implications for Viral Persistence, Immune Activation, and Immunometabolism
by: Eman Teer, et al.
Published: (2025-01-01)

Aspects of a Methodological Approach to Determination of Interferon Alpha Specific Activity
by: M. L. Baykova, et al.
Published: (2020-03-01)

The Value of the Interferon Inductors in the Treatment and Prevention of Respiratory Infections
by: O. V. Kladova, et al.
Published: (2016-11-01)

Interferon beta-1a in chronic inflammatory demyelinating polyneuropathy: case report Interferon beta en polineuropatía crónica inflamatoria desmienlinizante: caso clínico
by: Andrés Maria Villa, et al.
Published: (2004-09-01)

BAG2 Inhibits Cervical Cancer Progression by Modulating Type I Interferon Signaling through Stabilizing STING
by: Shijie Yao, et al.
Published: (2025-08-01)

Interferon-γ: biological function and application for study of cellular immune response
by: A. A. Lutckii, et al.
Published: (2016-02-01)

COPB1-knockdown induced type I interferon signaling activation inhibits Chlamydia psittaci intracellular proliferation
by: Nana Li, et al.
Published: (2025-03-01)

Finetuning Type I Interferon Signaling to Enhance T Cell Immunity in HIV Infection
by: Wenli Mu, et al.
Published: (2025-05-01)

The Pestivirus RNase E<sup>rns</sup> Tames the Interferon Response of the Respiratory Epithelium
by: Guillaume Beilleau, et al.
Published: (2024-12-01)

Age Matters: Key Contributors to Interferon Toxicity in Infants During Influenza Virus Infection
by: Abigail P. Onufer, et al.
Published: (2025-07-01)

Efficacy of interferon inducers against Chikungunya virus <i>in vitro</i>
by: E. V. Otrashevskaja, et al.
Published: (2023-12-01)

Diffuse traumatic brain injury induced stimulator of interferons (STING) signaling in microglia drives cortical neuroinflammation, neuronal dysfunction, and impaired cognition
by: Jonathan M. Packer, et al.
Published: (2025-04-01)

Chamomile Tincture and Lidocaine Hydrochloride Gel Ameliorates Periodontitis: A Preclinical Study
by: Jiahui Sun, et al.
Published: (2024-11-01)

IL1RA inhibits the progression of oral squamous cell carcinoma by mediating type Ⅰ interferon response
by: Yujie Ding, et al.
Published: (2025-08-01)

Double-filtration plasmapheresis reduces type I interferon bioavailability and inducing activity in systemic lupus erythematosus
by: Takumi Saito, et al.
Published: (2024-10-01)

Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations
by: Alaa A. Abdelmageed, et al.
Published: (2024-12-01)

IMMUNOINFLAMMATORY RHEUMATIC DISEASES ASSOCIATED WITH TYPE I INTERFERON: NEW EVIDENCE
by: E. L. Nasonov, et al.
Published: (2019-09-01)

Chasing Virus Replication and Infection: PAMP-PRR Interaction Drives Type I Interferon Production, Which in Turn Activates ISG Expression and ISGylation
by: Imaan Muhammad, et al.
Published: (2025-04-01)

Highly suitable LFBK cells for African swine fever virus replication and type I interferon-induced immune studies
by: Eun-Gyeong Lee, et al.
Published: (2025-06-01)

Herpetic infections in humans: modern approaches to etiopathogenetic therapy
by: D. S. Sukhanov, et al.
Published: (2025-06-01)

Determinants of functional cure in interferon-treated chronic hepatitis B: a retrospective cohort analysis of HBsAg dynamics and clinical predictors
by: Daqiong Zhou, et al.
Published: (2025-06-01)

The dual role of type I interferons in bacterial infections: from immune defense to pathogenesis
by: Mingjie Qiu, et al.
Published: (2025-07-01)

Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities
by: James Tumlin, et al.
Published: (2025-01-01)

Non-Invasive Detection of Interferon-Gamma in Sweat Using a Wearable DNA Hydrogel-Based Electrochemical Sensor
by: Yang Dai, et al.
Published: (2025-01-01)

Human type I interferons protect Vero E6 and ARPE-19 cells against West Nile virus and are neutralized by pathogenic autoantibodies
by: Alessandro Ferrari, et al.
Published: (2025-04-01)

Insights into regulatory T-cell and type-I interferon roles in determining abacavir-induced hypersensitivity or immune tolerance
by: Marco Cardone, et al.
Published: (2025-06-01)

Outer membrane vesicles of Glaesserlla parasuis activate the endosomal cGAS–STING–IRF3 pathway through nucleic acid payload delivery: a biological perspective on host defense protocol optimization
by: Kunli Zhang, et al.
Published: (2025-07-01)

Identification of genetic fingerprint of type I interferon therapy in visceral metastases of melanoma
by: Laura Vízkeleti, et al.
Published: (2024-11-01)

Phase transition of WTAP regulates m6A modification of interferon-stimulated genes
by: Sihui Cai, et al.
Published: (2025-05-01)

A zebrafish model of Ifih1-driven Aicardi–Goutières syndrome reproduces the interferon signature and the exacerbated inflammation of patients
by: Beatriz Bernal-Bermúdez, et al.
Published: (2023-11-01)

Corrigendum: A zebrafish model of Ifih1-driven Aicardi–Goutières syndrome reproduces the interferon signature and the exacerbated inflammation of patients
by: Beatriz Bernal-Bermúdez, et al.
Published: (2025-01-01)

Plasma CXCL4–DNA/RNA Complexes and Anti-CXCL4 Antibodies Modulation in an SSc Cohort under Iloprost Treatment
by: Anna Mennella, et al.
Published: (2024-08-01)

Digitoflavone Ameliorates Acute Lung Injury via Disturbing the Formation of Functional Stimulator of Interferon Genes Signalosome
by: Jun-Jie Li, et al.
Published: (2025-04-01)